Latest filing published 19 Aug 2024 for GeneDx Holdings Corp., €1.6M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -69.5%Entry US$12.70 · Close at T+365 US$3.88
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Opko Health, Inc.: trading record in brief
Opko Health, Inc. is a declared insider at 4 companies; the most frequent names are GeneDx Holdings Corp., Sorrento Therapeutics, Inc. and Eloxx Pharmaceuticals, Inc. We count 46 filings; the first trade dates from 7 August 2013 and the latest from 19 August 2024.
In open-market terms, that means 2 purchases worth €6.3M on one side and 39 sales worth €28.6M on the other. On balance, insiders were net sellers of €22.3M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants. In 2024 alone, the filings show no purchases and 19 sales.
The latest filing, published on 19 August 2024, reports an open-market sale of €1.6M in GeneDx Holdings Corp. The last insider purchase was made public on 31 January 2023, 1,378 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Opko Health, Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares@ US$34.304.9% of flowClass A Common StockSEC:0000950170-24-098688:1
- 50,000 shares@ US$34.494.9% of flowClass A Common StockSEC:0000950170-24-098688:2
- 39,824 shares@ US$33.08326.6% of flowClass A Common StockSEC:0000950170-24-098688:0
- 24,987 shares@ US$34.762.5% of flowClass A Common StockSEC:0000950170-24-097135:1
- 59,787 shares@ US$33.950710.1% of flowClass A Common StockSEC:0000950170-24-097135:0
- 100,000 shares@ US$31.829.1% of flowClass A Common StockSEC:0000950170-24-094224:1
- 12,994 shares@ US$29.35411.9% of flowClass A Common StockSEC:0000950170-24-094224:0
- 88,839 shares@ US$33.502715.0% of flowClass A Common StockSEC:0000950170-24-089997:0
- 50,000 shares@ US$33.85788.5% of flowClass A Common StockSEC:0000950170-24-088679:0
- 60,000 shares@ US$33.855.9% of flowClass A Common StockSEC:0000950170-24-087048:1
- 75,000 shares@ US$33.721412.7% of flowClass A Common StockSEC:0000950170-24-087048:0
- 50,000 shares@ US$32.614.7% of flowClass A Common StockSEC:0000950170-24-085751:1
- 75,000 shares@ US$33.467.3% of flowClass A Common StockSEC:0000950170-24-085751:2
- 25,000 shares@ US$32.294.0% of flowClass A Common StockSEC:0000950170-24-085751:0
- 25,000 shares@ US$32.92754.1% of flowClass A Common StockSEC:0000950170-24-085008:0
- 36,118 shares@ US$28.24125.2% of flowClass A Common StockSEC:0000950170-24-082411:0
- 25,000 shares@ US$29.122.1% of flowClass A Common StockSEC:0000950170-24-081596:1
- 14,082 shares@ US$28.231.2% of flowClass A Common StockSEC:0000950170-24-081596:2
- 50,000 shares@ US$26.6346.8% of flowClass A Common StockSEC:0000950170-24-081596:0
- 23,148,148 shares0Class A Common StockSEC:0001209191-23-024222:0
- 14,285,714 shares@ US$0.3525.0% of flowClass A Common StockSEC:0001209191-23-005821:0Canonical exit: 26 Apr 2023 (T+90)
- 495,126 sharesCommon StockSEC:0001209191-17-066864:0
- 1,250,006 shares0Common StockSEC:0001209191-17-059592:0
- 655,738 shares@ US$3.05100.0% of flowCommon StockSEC:0001209191-17-058591:0Canonical exit: 28 Jan 2018 (T+90)
- 1,563,123 shares@ US$0.1037.9% of flowCommon StockSEC:0001209191-17-048791:0
25 of 46 declarations
